BACKGROUND AND PURPOSE: CVR is a measure of cerebral hemodynamic impairment. A recently validated technique quantifies CVR by using a precise CO(2) vasodilatory stimulus and BOLD MR imaging. Our aim was to determine whether preoperative CO(2) BOLD CVR predicts the hemodynamic effect of ECIC bypass surgery in patients with intracranial steno-occlusive disease. MATERIALS AND METHODS: Twenty-five patients undergoing ECIC bypass surgery for treatment of intracranial stenosis or occlusion were recruited. CVR was measured preoperatively and postoperatively and expressed as %ΔBOLD MR signal intensity per mm Hg ΔPetCO(2). Using normative data from healthy subjects, we stratified patients on the basis of preoperative CVR into 3 groups: normal CVR, reduced CVR, and negative (paradoxical) CVR. Wilcoxon 2-sample tests (2-sided, α = 0.05) were used to determine whether the 3 groups differed with respect to change in CVR following bypass surgery. RESULTS: The group with normal preoperative CVR demonstrated no significant change in CVR following bypass surgery (mean, 0.22% ± 0.05% to 0.22% ± 0.01%; P = .881). The group with reduced preoperative CVR demonstrated a significant improvement following bypass surgery (mean, 0.08% ± 0.05% to 0.21 ± 0.08%; P < .001), and the group with paradoxical preoperative CVR demonstrated the greatest improvement (mean change, -0.04% ± 0.03% to 0.27% ± 0.03%; P = .028). CONCLUSIONS: Preoperative measurement of CVR by using CO(2) BOLD MR imaging predicts the hemodynamic effect of ECIC bypass in patients with intracranial steno-occlusive disease. The technique is potentially useful for selecting patients for surgical revascularization.
BACKGROUND AND PURPOSE: CVR is a measure of cerebral hemodynamic impairment. A recently validated technique quantifies CVR by using a precise CO(2) vasodilatory stimulus and BOLD MR imaging. Our aim was to determine whether preoperative CO(2) BOLD CVR predicts the hemodynamic effect of ECIC bypass surgery in patients with intracranial steno-occlusive disease. MATERIALS AND METHODS: Twenty-five patients undergoing ECIC bypass surgery for treatment of intracranial stenosis or occlusion were recruited. CVR was measured preoperatively and postoperatively and expressed as %ΔBOLD MR signal intensity per mm Hg ΔPetCO(2). Using normative data from healthy subjects, we stratified patients on the basis of preoperative CVR into 3 groups: normal CVR, reduced CVR, and negative (paradoxical) CVR. Wilcoxon 2-sample tests (2-sided, α = 0.05) were used to determine whether the 3 groups differed with respect to change in CVR following bypass surgery. RESULTS: The group with normal preoperative CVR demonstrated no significant change in CVR following bypass surgery (mean, 0.22% ± 0.05% to 0.22% ± 0.01%; P = .881). The group with reduced preoperative CVR demonstrated a significant improvement following bypass surgery (mean, 0.08% ± 0.05% to 0.21 ± 0.08%; P < .001), and the group with paradoxical preoperative CVR demonstrated the greatest improvement (mean change, -0.04% ± 0.03% to 0.27% ± 0.03%; P = .028). CONCLUSIONS: Preoperative measurement of CVR by using CO(2) BOLD MR imaging predicts the hemodynamic effect of ECIC bypass in patients with intracranial steno-occlusive disease. The technique is potentially useful for selecting patients for surgical revascularization.
Authors: Daniel M Mandell; Jay S Han; Julien Poublanc; Adrian P Crawley; Jeff A Stainsby; Joseph A Fisher; David J Mikulis Journal: Stroke Date: 2008-05-01 Impact factor: 7.914
Authors: Sven Haller; Leo H Bonati; Jochen Rick; Markus Klarhöfer; Oliver Speck; Philippe A Lyrer; Deniz Bilecen; Stefan T Engelter; Stephan G Wetzel Journal: Radiology Date: 2008-10 Impact factor: 11.105
Authors: Marat Slessarev; Jay Han; Alexandra Mardimae; Eitan Prisman; David Preiss; George Volgyesi; Cliff Ansel; James Duffin; Joseph A Fisher Journal: J Physiol Date: 2007-04-19 Impact factor: 5.182
Authors: L McKetton; L Venkatraghavan; C Rosen; D M Mandell; K Sam; O Sobczyk; J Poublanc; E Gray; A Crawley; J Duffin; J A Fisher; D J Mikulis Journal: AJNR Am J Neuroradiol Date: 2018-12-20 Impact factor: 3.825
Authors: Carlos C Faraco; Megan K Strother; Jeroen C W Siero; Daniel F Arteaga; Allison O Scott; Lori C Jordan; Manus J Donahue Journal: J Cereb Blood Flow Metab Date: 2015-07-15 Impact factor: 6.200
Authors: Carlos C Faraco; Megan K Strother; Lindsey M Dethrage; Lori Jordan; Robert Singer; Paul F Clemmons; Manus J Donahue Journal: Magn Reson Med Date: 2014-04-22 Impact factor: 4.668
Authors: Giovanni Muscas; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Giuseppe Esposito; Luca Regli; Jorn Fierstra Journal: Acta Neurochir Suppl Date: 2021